Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 5/20 | 0.48 |
| ▸ | PPARA | Q07869 | 3/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.42 |
| ▸ | CSNK1E | P49674 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10901230 | 1.00 | PPARG (0.48) | PPARGPPARAKMT2AKDM4EL3MBTL1 | |
| SCHEMBL28732572 | 1.00 | PPARG (0.48) | PPARGPPARAKMT2AKDM4EL3MBTL1 | |
| SCHEMBL11724981 | 1.00 | PPARG (0.48) | PPARGPPARAKMT2AKDM4EL3MBTL1 | |
| SCHEMBL8377476 | 1.00 | PPARG (0.48) | PPARGPPARAKMT2AKDM4EL3MBTL1 | |
| SCHEMBL11339313 | 1.00 | PPARG (0.48) | PPARGPPARAKMT2AKDM4EL3MBTL1 | |
| Ammonia Solution, Strong SCHEMBL29170081 | 0.98 | PPARG (0.47) | PPARGPPARAKMT2AKDM4EL3MBTL1 | |
| SCHEMBL7379765 | 0.98 | PPARG (0.46) | PPARGPPARAKMT2AKDM4EL3MBTL1 | |
| SCHEMBL6313224 | 0.93 | TSHR (0.46) | PPARGPPARAKMT2AKDM4EL3MBTL1 | |
| SCHEMBL30594196 | 0.89 | PPARG (0.43) | PPARGPPARAKMT2AKDM4EL3MBTL1 | |
| SCHEMBL2734713 | 0.88 | ALDH1A1 (0.47) | KMT2ATSHRALDH1A1CYP1A2CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090234151-A1 | Preparation of Mono-/Difluorinated Hydrocarbon Compounds | RHODIA CHIMIE (FR) | 2009-09-17 | — | — | US | disclosed |
| US-7557248-B2 | Method of forming a carbon-heteroatom bond | RHODIA CHIMIE (FR) | 2009-07-07 | — | — | US | disclosed |
| US-20070243999-A1 | Method of Forming a Carbon-Heteroatom Bond | RHODIA CHIMIE (FR) | 2007-10-18 | — | — | US | disclosed |
| US-6608232-B1 | Acylating an aromatic compound in presence of zeolite or friedel crafts catalyst, reduction to a carbinol and cata-lytic etherification | Chimie, Rhodia (FR) | 2003-08-19 | — | — | US | disclosed |
| US-6362378-B1 | REACTION WITH AN ALCOHOL; ZEOLITE CATALYST; PERFUMES | RHODIA CHIMIE (FR) | 2002-03-26 | — | — | US | disclosed |
| CN-1267277-A | Method for etherifying benzyl alcohol, resulting products and applications | RHODIA CHIMIE SA (FR) | 2000-09-20 | — | — | CN | disclosed |
| US-5786520-A | CATALYTIC VAPOR PHASE REACTION OF PHENOL COMPOUND WITH AN ALCOHOL | RHONE-POULENC CHIMIE (FR) | 1998-07-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090234151-A1 | Preparation of Mono-/Difluorinated Hydrocarbon Compounds | AHR, CYP2E1, CYP2F1 | PPARG 210/4885PPARA 159/4885KMT2A 614/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.